Previous screening for cervical cancer among women with cytological and histological abnormalities;Rastreamento anterior para câncer de colo uterino em mulheres com alterações citológicas ou histológicas

Revista de Saude Publica

Volumn 42, Issue 3, 2008, Pages 411-419

  Rama, Cristina Helena ^a   Roteli Martins, C ^a   Derchain, S ^b   Longatto Filho, A ^c   Gontijo, R ^b   Sarian, L ^b   Syrjanen, K ^d   Ching, T ^e   Aldrighi, J ^f  

^a HOSPITAL MATERNIDADE LEONOR MENDES DE BARROS   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c UNIVERSITY OF MINHO   (Portugal)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

^e FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

^f UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cross sectional studies; Diagnosis; Early diagnosis; Mass screening; Survivorship (Public Health); Uterine cervical neoplasms; Vaginal smears

Indexed keywords

EID: 48749131732     PISSN: 00348910     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0034-89102008000300004     Document Type: Article

References (22)

1. Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. J Clin Virol. 2005;32(Supl 1): S16-24.
2. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55(4):244-65.
3. Duarte-Franco E, Franco EL. Cancer of the uterine cervix. BMC Women's Health. 2004;4(Supl 1):S13.
4. Fahey MT, Irwig L, Macaskill P. Meta-analysis of Pap test accuracy. Am J Epidemiol. 1995;141(7):680-9.
5. Ferreccio C, Bratti MC, Sherman ME, Herrero R, Wacholder S, Hildesheim A, et al. A comparison of single and combined visual, cytologic and virologic tests and screening strategies in a region at high risk of cervical cancer. Cancer Epidemol Biomarkers Prev. 2003;12(9):815-23.
6. Forbes C, Jepson R, Martin-Hirsch P. Interventions target at women to encourage the uptake of cervical screening. Cochrane Database Syst Rev. 2002;(3): CD002834.
7. Franco EL, Duarte-Franco E, Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ. 2001;164(7): 1017-25.
8. Longatto Filho A, Utagawa ML, Pereira SMM, Pittoli JE, Aguiari LS, Maeda MYS, et al. Low- and high-risk HPV types detected with Hybrid Capture II (HC2) in Liquid-Based Cytology (DNA CITOLIQ®) System: Experience from the LAMS (Latin American Screening) study. J Bras Doencas Sex Transm. 2004;16(1):17-20.
9. Martins LFL, Thuler LCS, Valente JG. Cobertura do exame de Papanicolaou no Brasil e seus fatores determinantes: uma revisão sistemática da literatura. Rev Bras Ginecol Obstet 2005; 27(8):485-492.
10. McGoogan E. Liquid-based cytology. In: Monsonego J, editor. Emerging Issues on HPV Infections: From Science to Practice. Basel: Karger; 2006.
11. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med. 2000;132(10):810-9.
12. Nascimento CM, Eluf-Neto J, Rego RA. Pap test coverage in São Paulo municipality and characteristics of the women tested. Bull Pan Am Health Organ. 1996;30(4):302-12.
13. Pagliusi SR, Teresa Aguado M. Efficacy and other milestones for human papillomavirus vaccine introduction. Vaccine. 2004;23(5):569-78.
14. Pan American Health Organization. Cervical cancer in Latin America and the Caribbean: fact sheet 2001. Washington; 2001 [acesso em: 22/02/05]. Disponível em: http://www.ops-oms.org/English/AD/DPC/NC/ ccbriefsnapshot.pdf
15. Parkin DM, Pisani P, Ferlay J. Global Cancer Statistics. Cancer J Clin. 1999;49(1):33-64.
16. Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ. 2001;79(10):954-62.
17. Sasieni PD, Cuzick J, Lynch-Farmery E. Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group. Br J Cancer. 1996;73(8):1001-5.
18. Sasieni P, Fielder H, Rose B. Liquid-based versus conventional cervical cytology. Lancet. 2006;367(9521):1481-3.
19. Saslow D, Runowicz C, Solomon D, Moscicki AB, Smith RA, Eyre HJ, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. Cancer J Clin. 2002;52(6):342-62.
20. Scully RE, Bonfiguio TA, Kurman RJ, Silverberg SG, Wilkins EJ. Histologycal typing of female genital tract tumors. 2 ed. Berlin: Spring Verlag; 1994.
21. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287(16):2114-9.
22. Walker P, Dexeus S, De Palo G, Barrasso R, Campion M, Girardi F, et al. Nomenclature Committee of the International Federation for Cervical Pathology and Colposcopy. International terminology of colposcopy: an updated report from the International Federation for Cervical Pathology and Colposcopy. Obstet Gynecol. 2003;101(1):175-7.